Bausch Health Companies Inc. (BHC) stock
BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.47+0.05 (+0.59%)
Close on Nov 17, 2026Market cap $3.17BP/E –Yield –
Bausch Health Companies total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Bausch Health Companies's total debt was $20.64B at Sep 30, 2026. For fiscal 2025 it was $20.82B, down 3.7% from the year before. Over ten years it grew -3.9% a year on average. The highest annual figure on record is $31.10B in fiscal 2015.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.82B | -3.7% |
| FY2024 | Dec 31, 2024 | $21.62B | -3.4% |
| FY2023 | Dec 31, 2023 | $22.39B | +7.8% |
| FY2022 | Dec 31, 2022 | $20.77B | -8.3% |
| FY2021 | Dec 31, 2021 | $22.65B | -5.3% |
| FY2020 | Dec 31, 2020 | $23.93B | -7.6% |
| FY2019 | Dec 31, 2019 | $25.90B | +6.5% |
| FY2018 | Dec 31, 2018 | $24.31B | -4.5% |
| FY2017 | Dec 31, 2017 | $25.44B | -14.8% |
| FY2016 | Dec 31, 2016 | $29.85B | -4.0% |
| FY2015 | Dec 31, 2015 | $31.10B | +104.2% |
| FY2014 | Dec 31, 2014 | $15.24B | -12.3% |
| FY2013 | Dec 31, 2013 | $17.38B | +57.6% |
| FY2012 | Dec 31, 2012 | $11.03B | +65.8% |
| FY2011 | Dec 31, 2011 | $6.65B | +85.0% |
| FY2010 | Dec 31, 2010 | $3.60B | +1002.6% |
| FY2009 | Dec 31, 2009 | $326.09M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $20.64B | -1.9% |
| Q2 FY2026 | Jun 30, 2026 | $20.74B | -4.6% |
| Q1 FY2026 | Mar 31, 2026 | $20.76B | -3.5% |
| Q4 FY2025 | Dec 31, 2025 | $20.82B | -3.7% |
| Q3 FY2025 | Sep 30, 2025 | $21.04B | -2.2% |
| Q2 FY2025 | Jun 30, 2025 | $21.74B | +0.4% |
| Q1 FY2025 | Mar 31, 2025 | $21.51B | -2.6% |
| Q4 FY2024 | Dec 31, 2024 | $21.62B | -3.4% |
| Q3 FY2024 | Sep 30, 2024 | $21.51B | -4.1% |
| Q2 FY2024 | Jun 30, 2024 | $21.66B | +5.4% |
| Q1 FY2024 | Mar 31, 2024 | $22.07B | +6.9% |
| Q4 FY2023 | Dec 31, 2023 | $22.39B | +7.8% |
| Q3 FY2023 | Sep 30, 2023 | $22.43B | +5.7% |
| Q2 FY2023 | Jun 30, 2023 | $20.55B | -5.8% |
| Q1 FY2023 | Mar 31, 2023 | $20.65B | -10.9% |
| Q4 FY2022 | Dec 31, 2022 | $20.77B | -8.3% |
| Q3 FY2022 | Sep 30, 2022 | $21.22B | -5.1% |
| Q2 FY2022 | Jun 30, 2022 | $21.81B | -6.9% |
| Q1 FY2022 | Mar 31, 2022 | $23.17B | -2.4% |
| Q4 FY2021 | Dec 31, 2021 | $22.65B | -5.3% |
| Q3 FY2021 | Sep 30, 2021 | $22.36B | -8.2% |
| Q2 FY2021 | Jun 30, 2021 | $23.44B | -3.8% |
| Q1 FY2021 | Mar 31, 2021 | $23.74B | -2.8% |
| Q4 FY2020 | Dec 31, 2020 | $23.93B | -7.6% |
| Q3 FY2020 | Sep 30, 2020 | $24.34B | +3.3% |
| Q2 FY2020 | Jun 30, 2020 | $24.36B | +1.2% |
| Q1 FY2020 | Mar 31, 2020 | $24.43B | +1.0% |
| Q4 FY2019 | Dec 31, 2019 | $25.90B | +6.5% |
| Q3 FY2019 | Sep 30, 2019 | $23.57B | -4.7% |
| Q2 FY2019 | Jun 30, 2019 | $24.08B | -4.0% |
| Q1 FY2019 | Mar 31, 2019 | $24.18B | -4.3% |
| Q4 FY2018 | Dec 31, 2018 | $24.31B | -4.5% |
| Q3 FY2018 | Sep 30, 2018 | $24.73B | -8.9% |
| Q2 FY2018 | Jun 30, 2018 | $25.09B | -11.9% |
| Q1 FY2018 | Mar 31, 2018 | $25.27B | -11.5% |
| Q4 FY2017 | Dec 31, 2017 | $25.44B | -14.8% |
| Q3 FY2017 | Sep 30, 2017 | $27.14B | – |
| Q2 FY2017 | Jun 30, 2017 | $28.46B | – |
| Q1 FY2017 | Mar 31, 2017 | $28.55B | – |
| Q4 FY2016 | Dec 31, 2016 | $29.85B | – |
See a number that looks wrong?